Life Sciences/Biotech

NanoBio Secures Novel Antigen Source for its Intranasal RSV Vaccine

ANN ARBOR - NanoBio Corporation announced a licensing agreement with the National Institutes of Health that represents a significant step forward in developing the first vaccine to protect against respiratory syncytial virus infections. The agreement provides NanoBio with rights to a novel RSV antigen, developed by the NIH using proprietary viral-selection and reverse-genetics technology. RSV

By |2011-08-04T00:00:00-04:00August 4th, 2011|Archive, Life Sciences/Biotech|

Hygieia Gets $1.5 Million To Accelerate Product Commercialization

ANN ARBOR - Medical device maker Hygieia recently received $1.5 million from Oakwood Medical Investors, a physician-managed venture fund in St. Louis, Missouri. Hygieia has developed the Diabetes Insulin Guidance System, a handheld device that helps insulin-takers effectively manage their diabetes. DIGS adjusts insulin dosage weekly, to help patients get better. The investment comes on

By |2011-08-04T00:00:00-04:00August 4th, 2011|Archive, Life Sciences/Biotech|

Former HealthMedia CEO New Top Executive At Connecticut Software Startup

ANN ARBOR - Ted Dacko, former CEO of HealthMedia, has agreed to become CEO of a Connecticut-based budgeting software startup, but he doesn't plan to leave Michigan right away. Dacko is credited with helping to rescue Ann Arbor-based software firm HealthMedia from financial troubles and leading the company to a blockbuster sale to Johnson &

By |2011-08-04T00:00:00-04:00August 4th, 2011|Archive, Life Sciences/Biotech|

Van Andel Institute Names Whitescarver Chief Legal Officer

GRAND RAPIDS ? Van Andel Institute announced the appointment of David Whitescarver as Vice President and Chief Legal Officer effective August 1. Whitescarver is responsible for managing the legal affairs of VAI, Van Andel Research Institute, and Van Andel Education Institute and serving as secretary to the boards of these organizations. ?Mr. Whitescarver has a

By |2011-08-04T00:00:00-04:00August 4th, 2011|Archive, Life Sciences/Biotech|

5 BioChem Companies Win Scale-Up Help From MSU Holland Facility

HOLLAND ? Five Michigan-based technology companies have been named the winners of this year's "Scale Up Michigan!" competition, sponsored by Lakeshore Advantage and the Michigan State University Bioeconomy Institute, to help commercialize their products. The award recipients are: BoroPharm ? provides expertise in boron chemistry with custom synthesis solutions GFT, LLC ? manufactures polyimide insulating

By |2011-08-03T00:00:00-04:00August 3rd, 2011|Archive, Life Sciences/Biotech|

Spectrum Health Spin-Out Creates Web-based Tool To Manage Asthma

GRAND RAPIDS ? West Michigan serial entrepreneur, Keith Brophy, is the new Chief Executive Officer of Ideomed, a Spectrum Health backed start-up biomed company that has created a product called Abriiz to help children, parents and doctors manage pediatric asthma. Abriiz is a web-based health management platform to help children with asthma manage their condition.

By |2011-07-27T00:00:00-04:00July 27th, 2011|Archive, Life Sciences/Biotech|

Nano Bio To Start Human Studies On Flu Vaccine

ANN ARBOR - NanoBio Corporation announced that data from its ferret influenza vaccine study of NB-1008 have been published in the July 2011 issue of "Clinical Vaccine Immunology" by the American Society of Microbiology. Data generated from the study demonstrate the robust antigen-sparing properties of NB-1008 and provided the necessary validation to move immediately into

By |2011-07-21T00:00:00-04:00July 21st, 2011|Archive, Life Sciences/Biotech|

Wayne State Researcher Looks At Fatty Acids’ Link To Diabetes

DETROIT - Backed by several grants from the National Institutes of Health, James Granneman, professor of psychiatry and behavioral neurosciences and pathology in Wayne State University's School of Medicine, is examining the nature of how fatty acids link obesity and diabetes. As people become obese, their adipose tissue, which stores energy from food, loses its

By |2011-07-19T00:00:00-04:00July 19th, 2011|Archive, Life Sciences/Biotech|

Intervention Insights Lands $7.2 Million Series B Financing Round

GRAND RAPIDS - Intervention Insights, a health care IT company that helps community oncologists develop individualized patient treatment plans, announced Tuesday the close of $7.2 million in Series B financing. The deal was co-led by Michigan venture investor Beringea and Louisville, Ky.-based Chrysalis Ventures. They were joined by Hopen Life Sciences, Michigan Accelerator Fund I

By |2011-07-19T00:00:00-04:00July 19th, 2011|Archive, Life Sciences/Biotech|

VAI Scientists Look At Anti-Malaria Drug To Treat Autoimmune Diseases

GRAND RAPIDS ? In a study published recently in the journal "Science Signaling" Van Andel Research Institute scientists demonstrate on the molecular level how the anti-malaria drug chloroquine represses inflammation, which may provide a blueprint for new strategies for treating inflammation and a multitude of autoimmune diseases such as arthritis, multiple sclerosis, and certain cancers.

By |2011-07-19T00:00:00-04:00July 19th, 2011|Archive, Life Sciences/Biotech|